CYP24 inhibition preserves 1α,25-dihydroxyvitamin D3 anti-proliferative signaling in lung cancer cells
- 1 May 2012
- journal article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 355 (1) , 153-161
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Profiling 1,25-dihydroxyvitamin D3-regulated gene expression by microarray analysisThe Journal of Steroid Biochemistry and Molecular Biology, 2004
- Analysis of vitamin D‐regulated gene expression in LNCaP human prostate cancer cells using cDNA microarraysThe Prostate, 2003
- Vitamin D Growth Inhibition of Breast Cancer Cells: Gene Expression Patterns Assessed by cDNA MicroarrayBreast Cancer Research and Treatment, 2003
- Gene-expression profiles predict survival of patients with lung adenocarcinomaNature Medicine, 2002
- Inhibitory Effects of 1α,25-Dihydroxyvitamin D3 on the G1–S Phase-Controlling MachineryMolecular Endocrinology, 2001
- Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogeneNature Genetics, 2000
- Functional Assessment of Two Vitamin D-responsive Elements in the Rat 25-Hydroxyvitamin D3 24-Hydroxylase GeneJournal of Biological Chemistry, 1996
- Cloning of the human 1α,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elementsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1995
- The Steroid and Thyroid Hormone Receptor SuperfamilyScience, 1988
- SUPPRESSION OF INVIVO GROWTH OF HUMAN CANCER SOLID TUMOR XENOGRAFTS BY 1,25-DIHYDROXYVITAMIN-D31987